EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Exploring factors for predicting colchicine responsiveness in children with PFAPA

Zeynep Özaslan, Abdulvahap Şen, Sıla Atamyıldız Uçar, Mustafa Çakan, Bengisu Sanisoğlu, Feray Kaya, Gülçin Otar Yener, Ferhat Demir, Ayşe Tanatar, Semanur Özdel, Kübra Öztürk, Nihal Şahin und 3 weitere

European Journal of Pediatrics · 31.07.2024 · 183 (10) · 4337-4343

DOI: 10.1007/s00431-024-05703-3 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Pediatrics, online erschienen am 31.07.2024. Verfasst von Zeynep Özaslan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Rheumatology, Faculty of Medicine, MD, Kocaeli University, Kocaeli, Turkey. zeynepgozaluludag@gmail.com. Hauptthemen laut MEDLINE: Colchicine, Hereditary Autoinflammatory Diseases, Lymphadenitis, Pharyngitis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Kocaeli.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome (PFAPA) are the most common autoinflammatory syndromes in children. This study aimed to evaluate the clinical and laboratory parameters that may predict colchicine responsiveness.This retrospective, multicenter, cross-sectional study involved nine pediatric rheumatology centers from our country., The patients diagnosed with PFAPA were compared on the basis of their responses to colchicine. In the 806 (42.3% female 57.7% male) patients, the most common clinical findings were fever (100%), exudative tonsillitis (86.5%), pharyngitis (80.9%), and aphthous stomatitis (50.5%). The mean attack frequency was 13.5 ± 6.8 attacks per year lasting for a mean of 3.9 ± 1.1 days. Colchicine treatment was attempted in 519 (64.4%) patients, with 419 (80.7%) showing a favorable response. In patients who underwent MEFV gene analysis (70.8%), the most common variant was M694V heterozygous (16.8%). The presence of pharyngitis ( p = 0.03, 95% CI 0.885 to 0.994), the presence of arthralgia ( p = 0.04, 95% CI 0.169 to 0.958), and having more frequent attacks ( p = 0.001, 95% CI 0.028 to 0.748) were found to be associated with colchicine unresponsiveness, whereas the carriage of the M694V variant ( p = 0.001, 95% CI 0.065 to 0.242) was associated with colchicine responsiveness. Conclusion : This study identified the presence of pharyngitis, arthralgia, and increased attack frequency in patients with PFAPA as factors predicting colchicine unresponsiveness, whereas the carriage of the M694V variant emerged as a predictor of colchicine responsiveness. Predicting colchicine response at disease onset may facilitate a more effective management of PFAPA. What is Known :• Colchicine treatment can be used in the prophylaxis of PFAPA disease. • Having the MEFV variant is the most commonly known factor in predicting response to colchicine. What is New :• The presence of pharyngitis or arthralgia, and more frequent attacks in PFAPA disease were found to be independently associated with colchicine unresponsiveness. • Carrying the M694V variant was identified as the sole factor predicting colchicine responsiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineHereditary Autoinflammatory DiseasesLymphadenitisPharyngitisStomatitis, AphthousAdolescentChildChild, PreschoolFemaleHumansInfantMaleCross-Sectional StudiesFeverPyrinRetrospective StudiesSyndromeTreatment Outcome

Stichwörter der Autor:innen

MEFVColchicinePFAPATreatment response

Substanzen

ColchicineMEFV protein, humanPyrin

Autor:innen und Institutionen

  • Department of Pediatric Rheumatology, Faculty of Medicine, MD, Kocaeli University, Kocaeli, Turkey. zeynepgozaluludag@gmail.com.
  • Department of Pediatric Rheumatology, Ankara Etlik City Hospital, Ankara, Turkey.
  • Department of Pediatric Rheumatology, Health Sciences University, Umraniye Training and Research Hospital, Istanbul, Turkey.
  • Department of Pediatric Rheumatology, Zeynep Kamil Training and Research Hospital, Istanbul, Turkey.
  • Department of Pediatrics, Department of Pediatric Rheumatology, İstanbul University, Istanbul, Turkey.
  • Department of Pediatric Rheumatology, İstanbul Medeniyet University, İstanbul, Turkey.

Förderung

  • University of Kocaeli

Zitieren

APA

Özaslan, Z., Şen, A., Uçar, S. A., Çakan, M., Sanisoğlu, B., Kaya, F., Otar Yener, G., Demir, F., Tanatar, A., Özdel, S., Öztürk, K., Şahin, N., Sönmez, H. E., Aktay Ayaz, N., & Sözeri, B. (2024). Exploring factors for predicting colchicine responsiveness in children with PFAPA. European Journal of Pediatrics, 183(10), 4337-4343. https://doi.org/10.1007/s00431-024-05703-3

Vancouver

Özaslan Z, Şen A, Uçar SA, Çakan M, Sanisoğlu B, Kaya F, et al. Exploring factors for predicting colchicine responsiveness in children with PFAPA. European Journal of Pediatrics. 2024;183(10):4337-4343. doi:10.1007/s00431-024-05703-3

BibTeX
@article{zaslan2024,
  author = {Özaslan, Zeynep and Şen, Abdulvahap and Uçar, Sıla Atamyıldız and Çakan, Mustafa and Sanisoğlu, Bengisu and Kaya, Feray and Otar Yener, Gülçin and Demir, Ferhat and Tanatar, Ayşe and Özdel, Semanur and Öztürk, Kübra and Şahin, Nihal and Sönmez, Hafize Emine and Aktay Ayaz, Nuray and Sözeri, Betül},
  title = {Exploring factors for predicting colchicine responsiveness in children with PFAPA},
  journal = {European Journal of Pediatrics},
  year = {2024},
  volume = {183},
  number = {10},
  pages = {4337--4343},
  doi = {10.1007/s00431-024-05703-3}
}
Kostenlos starten →